|

Interpretation Bias as a Mechanism of Treatment Response in OCD

RECRUITINGN/ASponsored by Mclean Hospital
Actively Recruiting
PhaseN/A
SponsorMclean Hospital
Started2022-03-30
Est. completion2026-08-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive disorder (OCD). CBM-I is a digital intervention designed to directly manipulate interpretation bias through repeated practice on a training task, thereby inducing cognitive changes in a relatively automatic or implicit manner. Specifically, this study will examine the feasibility, acceptability, and clinical outcomes associated with CBM-I. Adults with obsessive compulsive disorder (OCD) will be recruited from a treatment program for this disorder and participants will be randomly assigned to either receive: 1) up to 12 sessions of CBM-I, or or up to 12 sessions of psychoeducation as a control condition.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* 1\) OCD Institute patients
* 2\) adults (\> 18 years old)
* 3\) able to complete a computer task for 20 minutes
* 4\) consent to main OCD Institute study protocol
* 5\) primary diagnosis of OCD (as measured by a score of \>16 on the Y-BOCS and a clinical diagnosis of OCD by their treatment team
* 6\) score of \>131 on the Obsessive Beliefs Questionnaire-44 at admission \[which is 1 SD above the mean score of the non-clinical sample reported in the original validation paper by the Obsessive Compulsive Cognitions Working Group (2005)\]

Exclusion Criteria:

* 1\) Currently experiencing acute symptoms of psychosis
* 2\) Psychotic disorder diagnosis

Conditions2

AnxietyObsessive-compulsive Disorder

Locations1 site

McLean Hospital
Belmont, Massachusetts, 02478
Martha Falkenstein617-855-4424mfalkenstein@mclean.harvard.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.